Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Outcome for Un-Audited Financial Results For The Quarter & Half Year Ended 30Th September, 2023

 This is to inform that the Board of Directors of the Company has, at its meeting held on Friday, 3rd November, 2023 (i.e. today), inter-alia, considered and approved the Un-audited Financial Results for the quarter & half year ended 30th September, 2023, along with the Limited Review Report of the statutory auditor. We are enclosing herewith the Un-audited Financial Results for the quarter & half year ended 30th September, 2023, along with a copy of the Limited Review Report by the Statutory Auditors of the Company. The Board meeting commenced at 3.30 p.m. and ended at 5.45 p.m.
03-11-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 the company has received intimation from the following shareholder regarding loss of share certificates: 1. Rajiv Nag- Folio.011627. 700 shares, certificate No- 9229-92235, Distinctive Nos. 77376401-77377100 2. Sandeep Gupta- Folio. 20723, 100 shares, Certificate No-2078, distinctive No -41387893-41387992 3. Vidyawati khandelwal- Folio .30679, 200 shares, Certificate no-34445-34446, Distinctive No-70864301-70864500 4. Suraj Prakash Bhasin, Folio No-26831,200 shares, Certificate No-159306-159307, Distinctive No- 84717201-84717400
31-10-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform you that the company has received intimation from the shareholders on 26th October, 2023, regarding loss of share certificates. In accordance with Regulation 39(3) of the regulations, as per details attached: 1.Malathi Manohar Folio No- 9908 No. of Shares-500 Certificates Nos- 83991-83995 Distinctive Nos-76552601-76553100 2. Kishore Kumar Folio No-14603 No. of Share-200 Certificate No- 105395-105396 Distinctive-78693001-78693200
27-10-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 30Th September 2023

 INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Friday, 3rd November, 2023, inter-alia, to consider and approve, the unaudited financial results for the quarter and half year ended 30th September, 2023.
20-10-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Enclosed please find a certificate dated 6th October, 2023 issued by M/s Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company for the quarter ended 30th September, 2023
14-10-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 we hereby summit copies of the public notice for transfer of shares to IEPF published on 12th October, 2023.
13-10-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Closure of Trading Window

 It is hereby inform that Trading Window for dealing in shares of the Company shall remains close w.e.f. 1st October, 2023 till 48 hours after the declaration of un-audited financial results for the quarter and half year ending 30th September, 2023.
26-09-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 The 35th AGM of the Company held on 21st September, 2023 through VC/OAVM. In this regard enclosed please find voting results as required under Regulation 44 of the SEBI (LODR) along with Report of Scrutinizer dated 22nd September, 2023
22-09-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby submit per annexure summary of the proceedings of the 35th Annual General Meeting of the Company held on 21st September, 2023, through VC/OAVM.
21-09-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Communication To The Shareholders Of The Company For The Deduction Of Tax At Source (TDS) On Dividend Payment

 Enclosed please find an Email communication sent to the shareholders on 2nd September,2023, for deduction of Tax at source (TDS) on dividend payment.
04-09-2023
Next Page
Close

Let's Open Free Demat Account